BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35291429)

  • 1. Challenge of Politico-Economic Sanctions on Pharmaceutical Procurement in Iran: A Qualitative Study.
    Bastani P; Dehghan Z; Kashfi SM; Dorosti H; Mohammadpour M; Mehralian G
    Iran J Med Sci; 2022 Mar; 47(2):152-161. PubMed ID: 35291429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran.
    Bastani P; Dehghan Z; Kashfi SM; Dorosti H; Mohammadpour M; Mehralian G; Ravangard R
    J Pharm Policy Pract; 2021 Jul; 14(1):56. PubMed ID: 34225794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.
    Setayesh S; Mackey TK
    Global Health; 2016 Jun; 12(1):31. PubMed ID: 27267898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical rehabilitation in Iran after international sanctions: explored findings from a qualitative study.
    Shahabi S; Teymourlouy AA; Shabaninejad H; Kamali M; Lankarani KB; Mojgani P
    Global Health; 2020 Sep; 16(1):86. PubMed ID: 32967707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration.
    Yousefi N; Moradi N; Dinarvand R; Ghiasi G; Inanloo H; Peiravian F
    Daru; 2019 Jun; 27(1):169-177. PubMed ID: 30903556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health system to response to economic sanctions: global evidence and lesson learned from Iran.
    Sajadi HS; Majdzadeh R
    Global Health; 2022 Dec; 18(1):107. PubMed ID: 36581892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human cost of economic sanctions and strategies for building health system resilience: A scoping review of studies in Iran.
    Sajadi HS; Yahyaei F; Ehsani-Chimeh E; Majdzadeh R
    Int J Health Plann Manage; 2023 Sep; 38(5):1142-1160. PubMed ID: 37194133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector.
    Emami F; Cheraghali AM
    Res Pharm Sci; 2022 Jun; 17(3):274-283. PubMed ID: 35531135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Effects of Economic Sanctions on Iranians' Right to Health by Using Human Rights Impact Assessment Tool: A Systematic Review.
    Kokabisaghi F
    Int J Health Policy Manag; 2018 May; 7(5):374-393. PubMed ID: 29764102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study.
    Ebadi Fardazar F; Sarabi Asiabar A; Safari H; Asgari M; Saber A; Ebadi Fard Azar AA
    Risk Manag Healthc Policy; 2019; 12():199-208. PubMed ID: 31807100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of international economic sanctions on Iranian cancer healthcare.
    Shahabi S; Fazlalizadeh H; Stedman J; Chuang L; Shariftabrizi A; Ram R
    Health Policy; 2015 Oct; 119(10):1309-18. PubMed ID: 26344426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of the Re-imposition of US Sanctions on Food Security in Iran.
    Hejazi J; Emamgholipour S
    Int J Health Policy Manag; 2022 May; 11(5):651-657. PubMed ID: 33160296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic sanctions threaten population health: the case of Iran.
    Aloosh M; Salavati A; Aloosh A
    Public Health; 2019 Apr; 169():10-13. PubMed ID: 30771721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iran, sanctions, and the COVID-19 crisis.
    Abdoli A
    J Med Econ; 2020 Dec; 23(12):1461-1465. PubMed ID: 33249954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sanctions on procurement of medicine and medical devices in Iran; a technical response.
    Hosseini SA
    Arch Iran Med; 2013 Dec; 16(12):736-8. PubMed ID: 24329148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iranian's healthcare system challenges during natural disasters: the qualitative case study of Kermanshah earthquake.
    Mohammadpour M; Sadeghkhani O; Bastani P; Ravangard R; Rezaee R
    BMC Emerg Med; 2020 Sep; 20(1):75. PubMed ID: 32972371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Sanctions and the Procurement of Medical Equipment in Iran: A Qualitative Study.
    Azami SR; Hosseini SM; Alimohammadzadeh K; Jafari M; Bahadori MK
    Med J Islam Repub Iran; 2021; 35():180. PubMed ID: 35706524
    [No Abstract]   [Full Text] [Related]  

  • 18. How the US Sanctions Are Affecting the Health Research System in Iran?
    Dehghani M; Mesgarpour B; Akhondzadeh S; Azami-Aghdash S; Ferdousi R
    Arch Iran Med; 2021 Feb; 24(2):101-106. PubMed ID: 33636976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative analysis of national documents on health care services and pharmaceuticals` purchasing challenges: evidence from Iran.
    Bastani P; Samadbeik M; Dinarvand R; Kashefian-Naeeini S; Vatankhah S
    BMC Health Serv Res; 2018 Jun; 18(1):410. PubMed ID: 29871679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran.
    Kheirandish M; Varahrami V; Kebriaeezade A; Cheraghali AM
    East Mediterr Health J; 2018 Apr; 24(1):42-51. PubMed ID: 29658620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.